首页 | 本学科首页   官方微博 | 高级检索  
检索        

右美托嘧啶临床应用的研究进展
引用本文:张晓琴.右美托嘧啶临床应用的研究进展[J].医学综述,2011,17(24):3789-3790.
作者姓名:张晓琴
作者单位:皖南医学院附属弋矶山医院麻醉科,安徽,芜湖,241000
摘    要:右美托嘧啶与可乐定相比是一种高选择性的α2受体激动剂,具有镇静、镇痛、抗焦虑、交感神经阻滞等作用。近年来,大量研究发现其还具有改善危重症患者长期的脑保护作用,已被广泛应用于消除谵妄、调整睡眠结构、机械通气、减轻交感兴奋及炎性反应等诸多临床实践中。右美托嘧啶也是区域麻醉的一种有效辅助手段,在临床使用中的风险/效益值仍需关注。

关 键 词:α2受体激动剂  右美托嘧啶  临床应用

Research Progress of Clinical Application of Dexmedetomidine
ZHANG Xiao-qin.Research Progress of Clinical Application of Dexmedetomidine[J].Medical Recapitulate,2011,17(24):3789-3790.
Authors:ZHANG Xiao-qin
Institution:ZHANG Xiao-qin,DAI Ze-ping.(Department of Anesthesiology,Yijishan Hospital Affiliated to Wannan Medical College,Wuhu 241001,China)
Abstract:Compared to clonidine, dexmedetomidine is a highly selective α2-receptor agonist, which of_ fers many beneficial properties, characterized by sedation, analgesia, resistance to anxiety and sympatholysis. A large body of recent work supports its favorable prolile in improving long-term brain function in the critical illness. It has been widely used in attenuating delirium, adjusting sleep structure, ventilatory driving and decreasing sympathetic tone and inflammatory responses etc.. Dexmedetomidine may also be a valuable adjuvant when regional anaesthesia is used. The risk/benefit ratio when it is used in the clinical practice still needs further study.
Keywords:α2-receptor agonist  Dexmedetomidine  Clinical application
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号